A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

This study is testing whether bone marrow from deceased donors can be used for bone marrow transplants in people with blood cancers. Currently, most transplants use living donors, but this approach could expand access for patients who cannot find a suitable living match. **You may be eligible if...** - You are 18–65 years old (or up to 75 for a less intense transplant regimen) - You have a blood cancer that requires a bone marrow transplant - You do not have a suitable living donor (related or unrelated) - The deceased donor bone marrow matches at least 4 out of 8 key immune markers (HLA) **You may NOT be eligible if...** - A suitable living donor is available - You have had a prior bone marrow or stem cell transplant - You are pregnant or breastfeeding - You have an active, uncontrolled infection Talk to your doctor to see if this trial is right for you.